Guiyi Gong‡
a,
Qinghua Lin‡a,
Jian Xua,
Feng Yea,
Lingling Jiangb,
Wenyuan Liucd,
Ming-Fang Heb,
Feng Feng*ae,
Wei Qu*ae and
Ning Xief
aDepartment of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China. E-mail: popoqzh@126.com; fengfeng@cpu.edu.cn; Fax: +86 25 86185216; Tel: +86 25 86185216
bInstitute of Translational Medicine College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211800, China
cDepartment of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
dKey Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China
eKey Laboratory of Biomedical Functional Materials, China Pharmaceutical University, Nanjing 211198, China
fState Key Laboratory of Innovative Natural Medicines and TCM Injections, Jiangxi Qingfeng Pharmaceutical Co., Ltd., Ganzhou 341000, Jiangxi, China
First published on 14th January 2016
Angiogenesis plays an important role in the development of inflammatory diseases, including cancer, psoriasis and rheumatoid arthritis. In this paper, we conducted a zebrafish bioassay-guided fractionation of Picrasma quassioides and identified twenty alkaloids from the anti-angiogenic fraction, including four new ones (1–4). In addition, in vivo relationship analyses of the structure and anti-angiogenic activity/toxicity led to the conclusion that the skeleton of alkaloids as well as the positions and properties of the substituents are pivotal to their activity and toxicity. Furancanthin (1) is the first-reported furan-fused canthin-6-one with an unprecedented highly-conjugated pentacyclic skeleton. 1-Hydroxymethyl-8-hydroxy-β-carboline (3) was found to have the most potent anti-angiogenic activity and the lowest toxicity in vivo, whose anti-angiogenic activity was also confirmed in vitro. Further qRT-PCR analysis revealed that the kdr, kdrl signaling axle in the VEGF–VEGFR pathway and the angpt2b, tek in the ANGPT–TEK pathway seemed to be involved in the anti-angiogenic activity of compound 3.
Picrasma quassioides (D. Don) Bennet, which tastes extremely bitter, is one of the most cited species in ancient Chinese medical treatise for a wide range of indications. Its twigs and barks are registered in present Chinese and Asian pharmacopoeias. Therefore, P. quassioides is traded across China and usually prescribed as an agent in cases of acute colic of the gastrointestinal sphere with or without diarrhea. But in Nepal, the extract of P. quassioides is applied to treat some intractable skin diseases (such as psoriasis and pruritus) and has significant efficacy.4
Previous studies have shown that P. quassioides contains a diverse range of bioactive phytochemicals, including alkaloids (β-carbolines and canthin-6-ones),5–7 quassinoids8 and triterpenoids.9 Nowadays, plenty of researches showed that the alkaloids from P. quassioides manifested potent anti-inflammatory effect10–12 and attracted our attention. In addition, many anti-inflammatory herbal medicines (such as Tripterygium wilfordii13,14 and Alpinia oxyphylla15) and natural products (such as indirubin16 and rhubarb17) showed considerable anti-angiogenic activities, which might serve as promising drug candidates for the treatment of diseases with abnormally activated angiogenesis. Therefore, it is conceivable that P. quassioides and its alkaloids possess potential anti-angiogenic properties. Although β-carbolines and canthin-6-ones have been reported to have promising anti-inflammatory activities,10–12 the effect of these alkaloids on angiogenesis remains unclear. Only two recent studies touched on the anti-angiogenic effect of one β-carboline alkaloid, harmine.18,19 Moreover, it remains unclear that the relationship between the chemical structure diversity of β-carboline alkaloids and the corresponding anti-angiogenic activity.
In recent years, in vivo chemical screening in zebrafish (Tg(flia:EGFP)) has emerged as an ideal method to study anti-angiogenic substances and identify promising lead compounds.20–24 Moreover, by performing this method, researchers could not only determine the bioactivity and toxicity against the vasculature development in zebrafish embryos, but also conduct structure–activity and structure–toxicity relationships (SAR and STR) studies.25 In this report, we carried out a phytochemical investigation into the bio-active fraction and the constitutive β-carboline alkaloids, then their SAR and STR on anti-angiogenesis were also discussed using in vivo zebrafish model. Finally, the action mechanism of a novel β-carboline alkaloid, which had the best therapeutic window, was evaluated.
Compound 1 was obtained as white floc. Its molecular formula was established as C17H10N2O3 from the positive-mode HR-ESI-MS ion at m/z 291.0767 [M + H]+ (calcd [C17H10N2O3+H]+, 291.0764), indicating 13 degrees of unsaturation. The 1H NMR spectrum (Table 1) of 1 displayed six well-splitted aromatic proton signals (δH 7.29, 7.58, 7.77, 8.28, 8.36, 8.56 and 8.84) that possess 5.7 Hz, 8.1 Hz coupling constants, one hydroxymethyl signal (δH 4.71, 2H d and 5.81, 1H t) and one olefinic proton (δH 7.29, 1H s), suggested the canthinone-type skeleton for 1. The 13C NMR spectrum (Table 1) showed 17 carbon resonances, and aided by HSQC experiments, we categorized them into one methylene (δC 56.1); seven methines, and nine quaternary carbons including three oxygenated aromatic carbons or carbonyl carbons (δC 145.2, 150.6, 163.9), collectively corresponding to the molecular formula C17H10N2O3. Then we confirmed 1 as a canthin-6-one instead of a canthin-4-one on the basis of comparison with NMR data of reported drymaritin.26 Furthermore, compared with those of 5-hydroxymethylcanthin-6-one,27 which possessed 11 degrees of unsaturation, we noticed that a downshift of olefinic proton of 1 from 8.02 to 7.29. Additionally, two other quaternary carbons and unsaturation appeared. The key HMBC correlations (Fig. 2) from CH2-1′ (δH 4.71) to C-4 (δC 163.9) and C-5a (δC 103.4), from OH (δH 5.81) to C-1′ (δC 56.1) and C-4 (δC 163.9), from olefinic proton (δH 7.29) to C-4a (δC 145.2), C-4 (δC 163.9) and C-5 (δC 132.0) revealed a hydroxymethylfuran group in 1, which might contributed to the extra quaternary carbons and unsaturation. Notably, the correlations from H-1 (δH 8.28) to C-4a (δC 145.2) and from H-2 (δH 8.84) to C-5 (δC 132.0) in HMBC experiments can lead to the presence of hydroxymethylfuran group, and the disconnection of oxygenated aromatic carbon and carbonyl carbon. Thus, 1 was determined as 4-hydroxymethyl-canthin[4,5-b]furan-6-one, named furancanthin, which is the first-reported furan-fused canthin-6-one with an unprecedented pentacyclic high-conjugated skeleton.
Position | 1 | 2 | ||||
---|---|---|---|---|---|---|
δH mult (J in Hz) | δC | HMBC (H to C) | δH mult (J in Hz) | δC | HMBC (H to C) | |
1 | 8.28 (1H, d, 5.1) | 115.9 | 4a, 12, 14, 15 | 7.95 (1H, d, 5.1) | 115.0 | 2, 15 |
2 | 8.84 (1H, d, 5.1) | 145.4 | 1, 5, 15, 16 | 8.72 (1H, d, 5.1) | 145.6 | 1, 14 |
4 | 163.9 | 7.40 (1H, s) | 109.9 | 6, 15, 16 | ||
4a | 145.2 | |||||
5 | 7.29 (1H, s) | 103.4 | 4, 4a, 5 | 153.5 | ||
5a | 132.0 | |||||
6 | 150.6 | 154.3 | ||||
8 | 8.56 (1H, d, 8.2) | 116.2 | 11, 12, 13 | 7.98 (1H, d, 8.1) | 107.0 | 12 |
9 | 7.77 (1H, t, 5.7) | 130.8 | 10, 11, 13 | 7.57 (1H, t, 8.1) | 131.6 | 11, 13 |
10 | 7.58 (1H, t, 5.7) | 125.4 | 8, 9, 12, 13 | 7.02 (1H, d, 8.2) | 111.9 | 8, 12 |
11 | 8.36 (1H, d, 8.2) | 123.5 | 8, 13, 14 | 154.8 | ||
12 | 124.8 | 112.3 | ||||
13 | 138.6 | 139.4 | ||||
14 | 130.1 | 127.4 | ||||
15 | 132.4 | 126.0 | ||||
16 | 129.6 | 135.5 | ||||
1′ | 4.71 (2H, d, 5.9) | 56.1 | 4, 5a | |||
1′-OH | 5.81 (1H, t, 6.0) | 1′, 4 | ||||
5-OCH3 | 3.99 (3H, s) | 56.5 | 5 | |||
11-OH | 11.02 (1H, s) | 11, 12, 13 |
Compound 2 was isolated as yellow amorphous powder. Its HR-ESI-MS showed an [M + H]+ ion at m/z 267.0765 (calcd [C15H10N2O3+H]+, 267.0764), indicated a molecular formula of C15H10N2O3, which possesses 11 indices of hydrogen deficiency. The 1H NMR spectrum (Table 1) of 2 exhibited the resonances of one methoxy group (δH 3.99, 3H s), one reactive proton (δH 11.02, OH s), five aromatic proton (δH 7.02, 7.57, 7.95, 7.98 and 8.72) and one olefinic proton (δH 7.40, 1H s), suggesting the presence of a one-substituted carboline-type moiety. The 13C NMR (Table 1) and HSQC data revealed the presence of one methoxy (δC 56.5); six methines and eight quaternary carbons including three oxygenated aromatic carbons or carbonyl carbons (δC 153.5, 154.3, 154.8), implied a canthinone core skeleton. Compared the spectral data of 2 to those of 5-methoxycanthin-6-one,28 we easily found that they were quite similar except for a oxygenated-aromatic carbon. The correlations (Fig. 2) from OCH3 (δH 3.99) to C-5 (δC 153.5), from olefinic proton (δH 7.40) to C-6 (δC 154.3), C-15 (δC 126.0) and C-16 (δC 135.5), from OH (δH 11.02) to C-11 (δC 154.8), C-12 (δC 112.3) and C-13 (δC 139.4), from aromatic proton (δH 7.57) to C-11 (δC 154.8) and C-13 (δC 139.4) observed in HMBC confirmed the location of methoxy group was at C-5 while OH group at C-11. Therefore, the structure of 2 was determined as 11-hydroxy-5-methoxycanthin-6-one.
Compound 3 was obtained as brown needle. The molecular formula was established as C12H10N2O2 based on its HR-ESI-MS [M − H]− ion peak at m/z 213.0650 (calcd [C12H11N2O2 − H]−, 213.0659). The 1D NMR and HSQC spectroscopic data of 3 (Table 2) suggested its β-carboline skeleton and displayed one hydroxymethyl group, one hydroxy group. The comparison of the NMR data between 3 and 1-hydroxymethyl-β-carboline (9) revealed an extra hydroxy group in 3, which was also confirmed by its molecular formula.29 The small sample size of 3 prevented acquisition of a 13C NMR spectrum with adequate signal to noise ratio. But HMBC correlations (Fig. 3) from CH2 (δH 4.99) to C-1 (δC 145.4) and C-9 (δC 133.4), from aromatic proton (δH 6.95) to C-5 (δC 112.8), C-8a (δC 131.1) and C-8 (δC 144.2), from proton (δH 7.07) to C-4b (δC 122.7) and C-8 (δC 144.2), from OH (δH 10.05) to C-7 (δC 112.9), C-8 (δC 144.2) and C-8a (δC 131.1) suggested that the hydroxymethyl group substituted at C-1 while the hydroxy group at C-8. Thus, 3 was established as 1-hydroxymethyl-8-hydroxy-β-carboline.
Position | 3 | 4 | ||||
---|---|---|---|---|---|---|
δH mult (J in Hz) | δC | HMBC (H to C) | δH mult (J in Hz) | δC | HMBC (H to C) | |
a Chemical shifts marked with an asterisk (*) indicate overlapped signals. | ||||||
1 | 145.4 | 129.2 | ||||
3 | 8.23 (1H, d, 5.3) | 136.4 | 1, 4, 4a | 8.39 (1H, d, 4.7) | 136.6 | 1, 4, 4a, 9a |
4 | 8.00 (1H, d, 5.5) | 114.5 | 4b, 8 | 8.31 (1H, d, 4.6) | 118.4 | 4a, 4b, 9a |
4a | 129.3 | 130.1 | ||||
4b | 122.7 | 120.4 | ||||
5 | 7.67 (1H, d, 8.1) | 112.8 | 4b, 7, 8a | 7.58 (1H, s) | 105.4 | 4a, 7, 8a |
6 | 7.07 (1H, t, 7.8) | 120.9 | 4b, 8 | 151.1 | ||
7 | 6.95 (1H, d, 7.5) | 112.9 | 5, 8, 8a | 7.12 (1H, d, 8.6) | 118.6 | 5, 8a |
8 | 144.2 | 7.60* (1H, m) | 113.0 | 4b, 6 | ||
8a | 131.1 | 134.9 | ||||
9a | 133.4 | 136.1 | ||||
1′ | 4.99 (2H, d, 5.7) | 63.3 | 1, 9a | |||
1′-OH | 5.57 (1H, t, 5.7) | 5, 8, 8a | ||||
8-OH | 10.05 (1H, s) | 7, 8, 8a | ||||
NH | 11.09 (1H, s) | 11.39 (1H, s) | 4a, 4b, 9a | |||
1′-CO– | 165.2 | |||||
2′-OCH2– | 4.48 (2H, q, 7.0) | 60.4 | 1′, 3′ | |||
3′-CH3 | 1.41 (3H, t, 7.0) | 14.0 | 2′ |
Compound 4 was isolated as yellow syrup. The positive-mode HR-ESI-MS of 4 gave the ion peak at m/z 257.0919 (calcd [C14H12N2O3+H]+, 257.0921), which was consistent with the molecular formula C14H12N2O3. The 1H NMR spectrum (Table 2) displayed signals for NH at δ 11.39, besides, a set of ABX aromatic signals (δH 7.12, 1H d, 7.58, 1H m, 7.60, 1H m) indicated the presence of a mono-substituted aromatic A ring of β-carboline and the substitutes at C-6 or C-7. The ortho coupled doublets (δH 8.31 and 8.39) with smaller coupling constant of 4.7 Hz were typical of heteroaromatic protons, H-4 and H-3 of β-carboline skeleton. The proton signals (δH 1.41, 3H t and 4.48, 2H q) and three carbon signals (δC 14.0, 60.4, 165.2) (Table 2) suggested the presence of an ethoxycarbonyl group at C-1. The β-carboline ring and ethoxycarbonyl chain accounted for C14H11N2O2, with an unaccounted HO from the molecular formula C14H12N2O3. This suggested the possibility of a hydroxy moiety being the missing fragment of 4.30 Comparison of the spectral basis between 4 and 6-hydroxy-1-methoxycarbonyl-β-carboline showed the location of the OH moiety at C-6.31 In its HMBC experiments, the correlations (Fig. 3) from aromatic proton (δH 7.12) to C-5 (δC 105.4), C-8a (δC 134.9) and C-6 (δC 151.1), from proton (δH 7.58) to C-7 (δC 118.6), C-4a (δC 130.1), C-8a (δC 134.9) and C-6 (δC 151.1), from proton (δH 7.60) to C-4b (δC 120.4) and C-6 (δC 151.1) fully supported the assignments above. Hence, 4 was assigned as 6-hydroxy-1-ethoxycarbonyl-β-carboline.
The known compounds 4,5-dimethoxy-canthin-6-one (5),32 4-methoxy-5-hydroxy-canthin-6-one (6),32 canthin-6-one (7),28 1-aldehyde-β-carboline (8),33 1-hydroxymethyl-β-carboline (9),29 β-carboline-1-carboxylic acid (10),30 β-carboline-1-propionic acid (11),32 1-ethoxycarbonyl-β-carboline (12),34 1-formyl-β-carboline (13),34 1,6-dihydroxy-β-carboline (14),35 1-hydroxy-β-carboline (15),35 4-hydroxy-1-methoxycarbonyl-β-carboline (16),35 4-methoxyl-1-methoxycarbonyl-β-carboline (17),36 4,8-dimethoxy-1-vinyl-β-carboline (18),28 1-carbonyl-6-dihydroxy-β-carboline (19)35 and 4,5-dimethoxy-10-hydroxy-canthin-6-one (20)7 were identified by comparison of their observed and reported NMR data.
Compounds 1–20 at various concentrations were tested for their anti-angiogenic activities and toxicities on transgenic zebrafish from 24 hpf to 72 hpf. The lowest observed effect concentration (LOEC) in terms of anti-angiogenesis, totally lethal concentration (LC100), and anti-angiogenic index (AI, AI = LC100/LOEC) values were estimated (Table 3).21,23,24,39
Compound | ClogP | LOEC (μM) | LC100 (toxicity, μM) | AI |
---|---|---|---|---|
a ClogP values: calculated from Chem3D. LOEC: lowest observed effect concentration, it was the treatment concentration that resulted in anti-angiogenic effects on most of the zebrafish larval population; LC100: totally lethal concentration, it was a concentration that resulted in 100% mortality of the embryos during the incubation period; AI: anti-angiogenic index, LC100/LOEC, was considered as the concentration range between LOEC and LC100, it revealed the sub-lethal effects of the compounds with respect to its efficacious concentrations. N.d., not determined due to precipitation. N/A, not applicable. For comparison, the effects of the known KDR inhibitor SU5416 are shown at the bottom. Results from at least 20 embryos per condition. | ||||
1 | 2.00 | N.d. | N.d. | N/A |
2 | 2.25 | >200 | >200 | 1 |
3 | 1.54 | 25 | 150 | 6 |
4 | 2.39 | 150 | 200 | 1.3 |
5 | 2.43 | >25 | 25 | <1 |
6 | 2.42 | >5 | 5 | <1 |
7 | 2.27 | >200 | >200 | 1 |
8 | 2.48 | 5 | 10 | 2 |
9 | 1.97 | >200 | >200 | 1 |
10 | 2.91 | N.d. | N.d. | N/A |
11 | 2.32 | >200 | >200 | 1 |
12 | 2.81 | 75 | 150 | 2 |
13 | 2.79 | >200 | >200 | 1 |
14 | 2.42 | >200 | >200 | 1 |
15 | 2.85 | 100 | >200 | 2 |
16 | 2.65 | 100 | 150 | 1.5 |
17 | 2.66 | >10 | 10 | <1 |
18 | 3.75 | 25 | 50 | 2 |
19 | 0.57 | N.d. | N.d. | N/A |
20 | 2.16 | >200 | >200 | 1 |
SU5416 | 2.83 | 1 | 5 | 5 |
As the current data showed (Table 3), the structural diversity of these alkaloids and their anti-angiogenic effects/toxicity roughly defined some structure–activity/toxicity relationships. First of all, the alkaloid skeleton (β-carboline type or canthinone type) might be crucial in the determination of their structure–activity/toxicity. Most of the tested β-carbolines displayed visible anti-angiogenic effects and had satisfactory AI values while few canthin-6-ones exhibited observable phenotype. Only two canthinones (5 and 6), showing strong toxicity on zebrafish at low concentration 25 and 5 μM, respectively, inhibited angiogenisis when the larvae were dying. On the contrary, other canthinones, including 1, 2, 7, 20, manifested no anti-angiogenic effect and little toxicity to the larvae. In addition, we noticed that compound 3, 4, 8, 12, 15, 16 and 18 could exhibit different potency and effectiveness of the anti-angiogenic activities on zebrafish when the embryos were alive and with comparable body morphology and structure to those in control groups (in Table 4). All these alkaloids are β-carbolines. The survival rate of zebrafish embryos and the anti-angiogenic activity of these compounds at 72 hpf were summarized in Table 4 for better clarification. These findings suggested that canthinone-type skeleton might be inferior to β-carbolines with regard to the anti-angiogenic function.
Number | Concentration (μM) | |||||||
---|---|---|---|---|---|---|---|---|
5 | 10 | 25 | 50 | 75 | 100 | 150 | 200 | |
a The data are presented as mean ± SEM of at least three individual experiments. + is the estimated arbitrary unit of anti-angiogenic activity of the alkaloids. +, mild; ++, moderate; +++, strong. | ||||||||
3 | 100 | 100 | 100(+) | 100(++) | 78.3 ± 7.6(+++) | 60.0 ± 15.0(+++) | 0 | 0 |
4 | 100 | 100 | 100 | 100 | 100 | 93.3 ± 2.9 | 83.3 ± 2.9(+) | 0 |
8 | 68.3 ± 7.6(+) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
12 | 100 | 100 | 100 | 100 | 98.3 ± 2.9(+) | 46.7 ± 10.4(++) | 0 | 0 |
15 | 100 | 100 | 100 | 100 | 100 | 100(+) | 100(++) | 100(+++) |
16 | 100 | 100 | 100 | 100 | 100 | 93.3 ± 7.6(+) | 0 | 0 |
18 | 100 | 100 | 82.7 ± 12.6(+) | 0 | 0 | 0 | 0 | 0 |
Besides, the position of substituents also exerted a tremendous influence on the activity and toxicity of these alkaloids. For example, substitutions at C-4 and C-5 in canthinones can seemingly modulate toxicity. Compound 5 and 6, which possess dual substitutions, affected the development of zebrafish embryos and appeared more toxic than the canthinones with mono-substituted or without one. Notably, compound 5 poisoned and killed the larvae at 25 μM while 20 was a safe compound for zebrafish up to 200 μM, suggesting that an additional OH group at C-10 might reduce toxicity. Similarly, the comparison of the anti-angiogenic activity of 4 with 12 (Table 4) could reveal that the substituents at position C-6 also viably resulted in decreased activity and toxicity to zebrafish, which was further confirmed by comparing 14 and 15 (Table 4). Interestingly, the observed increase in anti-angiogenic activity from 9 to 3 indicated that an OH substituent at C-8 might provide a higher chance to prevent vasculature formation.
Finally, we realized that substituents could had a drastic effect on the anti-angiogenic activity and toxicity to zebrafish. For instance, it was presumably that the hydroxy group, wherever substituted at β-carboline skeleton, could lower the toxicity to zebrafish while the replacement of a methoxy group might bring about opposite effect, as indicated by 17, 18 vs. 16. In contrast to β-carbolines, canthinone 5 was safer than 6 to zebrafish, which implied that the methoxy group at canthinones exhibited lower toxicity than hydroxy group. However, these substituents' influences on the anti-angiogenic activity remained unknown and were likely dependent on their substituted positions. From the analysis of the anti-angiogenic β-carbolines in Table 4, it could be concluded that an ester group at C-1 was possibly more active and toxic to zebrafish than carbonyl and hydroxy group, which revealed that a suitable substituent at C-1 play a key role in the anti-angiogenic activity. Compound 8 was far more toxic than other carbolines, which indicated that the aldehyde group at C-1 probably increase toxicity.
In summary, our data indicated that the alkaloid skeleton, substitutions at C-4 and C-5 (canthinones), presence of substituents at C-6 (β-carbolines) or C-10 (canthinones), variation of substituents at C-1 (β-carbolines) could significantly affect the anti-angiogenic activity and toxicity on zebrafish embryos.
Besides, cells migration is a key step shared by both angiogenesis and tumor progression. Fig. 6A showed the effects of different concentrations of 3 on endothelial cell vertical migration ability, as determined by Boyden Chamber migration assay. Quantitative determination of the migrated cells showed a significant inhibitory effect of 3 at more than 25 μM (Fig. 6B). Additionally, 3 could inhibit HUVEC horizontal migration ability in a scratch-wound assay (Fig. 6C), achieving about 40% inhibition at 50 μM (Fig. 6D).
Tube formation is also indispensable for angiogenesis. The tubular structure in the treated wells was rather incomplete with fewer branch points and shorter tube length (Fig. 7A). 3 showed an inhibitory effect by about 30% and 70% at 50 μM and 100 μM respectively on HUVECs (Fig. 7B), which was comparable to the positive control.
All of the in vitro results showed that 3 could inhibit the three key steps including proliferation, migration and tube formation of HUVEC involved in the angiogenesis progress. Interestingly, 3 showed preferentially inhibition to HUVEC migration than proliferation and tube formation.
We conducted the SAR and STR studies in live zebrafish embryos, which are inherently likely to assess absorption, distribution, metabolism, excretion, and toxicity (ADMET) and identify compounds having favorable physiochemical properties and excellent “drug-likeness”. Our results demonstrate that the zebrafish model is a correlative, convenient and complementary platform for pharmaceutical development that incorporates the assessment of a lead compound's in vivo bioactivity and selectivity in the early development process.
Our findings bring new and strong evidence that β-carboline type alkaloids might serve as promising anti-angiogenic candidates. Further structural modifications of β-carbolines are still underway. Since these alkaloids' anti-inflammatory and anti-angiogenic activities were codependent, their relationships will also be explored in the future.
The pH 9 fraction (45 g) was subjected to silica gel CC and eluted with CH2Cl2–MeOH (50:1–50:50) to give 8 subfractions (9.1–9.8). Fraction 9.2 was subjected to an ODS-MPLC using a gradient elution with MeOH/H2O (10:90–100:0) to afford four fractions, and the fourth fraction 9.2.4 was further separated on RP-TLC (CHCl3/MeOH 20:1) to get 18 (4 mg), 20 (3 mg). Purification of fraction 9.3 on Sephadex LH-20 CC using an isocratic elution with CHCl3/MeOH (1:1) to yield 9 (30 mg), 14 (2 mg), 15 (2 mg), 19 (30 mg). Subfraction 9.4 was further purified by repeated silica gel CC and 1 (4.3 mg), 2 (3 mg), 5 (>1 g), 8 (20 mg), 10 (6 mg), 16 (20 mg), 6 (>2 g) was obtained by recrystallized. Fraction 9.5 was subjected to a silica gel CC using a step gradient of CHCl3/MeOH (30:1–8:2) as eluent to furnish five fractions, and the fifth fraction 9.5.5 was purified by Sephadex LH-20 CC eluted with isocratic CHCl3/MeOH (1:1) to give compound 3 (1 mg). The fraction 9.5.4 was purified on semi-RP-HPLC (60% MeOH, 2 mL min−1) to yield compounds 4 (5 mg), 13 (3 mg). Subfraction 9.6 (5 g) was repeatedly chromatographed over MCI gel (MeOH/H2O 1:9–7:3), silica gel (CH2Cl2/actone 10:1–6:1), Sephadex LH-20 (CH2Cl2/MeOH 1:1), ODS (MeOH/water 3:7–5:5) to afford 7 (2.5 mg), 11 (6.3 mg), 12 (8 mg), 17 (5 mg). The purity of compounds 1–20 was estimated to be greater than 90%, as determined by 1H NMR spectra.
Footnotes |
† Electronic supplementary information (ESI) available: Extensive experimental methods, 1D NMR, 2D NMR, HRESIMS spectra of 1–4 and bioassay-guided fractionation results. See DOI: 10.1039/c5ra22391a |
‡ These authors contributed equally to this work. |
This journal is © The Royal Society of Chemistry 2016 |